axicabtagene ciloleucel
Gilead,Daiichi Sankyo
['bet', 'equate', '#166', 'axi-cel', 'fil,veral,12', 'leukemia', 'lymphoma', 'lymsm', 'effector ']
congress | #ash22 , presents a primary analysis of the phase ii alycante study of axi-cel in transplant ineligible #lbcl patients. the study met its primary endpoints, with axi-cel appearing to be a safe and efficacious therapy for this patient group. #lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm